Challenges for opioid receptor nomenclature: IUPHAR Review 9.
about
Treatment of Cancer Pain by Targeting CytokinesFunctional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonistsPositive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medicationsAnti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonistBU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice.Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitroRecent advances on the δ opioid receptor: from trafficking to function.In vivo opioid receptor heteromerization: where do we stand?β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin AEffect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord.Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization.Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.Central N/OFQ-NOP Receptor System in Pain Modulation.The mu opioid receptor: A new target for cancer therapy?Buprenorphine--the unique opioid adjuvant in regional anesthesia.Clinical Pharmacokinetic Characteristics of Cebranopadol, a Novel First-in-Class Analgesic.Cebranopadol: novel dual opioid/NOP receptor agonist analgesic.In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5.Endothelin-converting enzyme 2 differentially regulates opioid receptor activity.Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.Themed section.Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.Conformational Heterogeneity of Intracellular Loop 3 of the μ-opioid G-protein Coupled Receptor.Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.Pharmacological Evidence for a Putative Conserved Allosteric Site on Opioid Receptors.
P2860
Q26779917-F4DD164F-30DE-4FF1-A948-047188441AE5Q26852027-2378F3D0-63E5-403F-8EB3-89EE5F334EF0Q27027736-3963A7CC-C84A-45CC-8B3E-FC4C63D0D27DQ28652289-9BC387A2-C2D1-43D1-84AE-6768742F4FE2Q34423181-A6B941C9-4D8A-4A60-9115-5EA11F836743Q34559598-AE24386A-76D6-4DE8-9FB9-9FE86AB7FB77Q34939664-3910CEE2-3D9A-4D67-ACEC-7C31E0801B96Q34939677-77040661-A297-49AB-8B88-034C5EABD81AQ34939769-1397F6B8-1BBF-462D-8B07-8EB4DE13351BQ34939810-D45B8045-A4D4-4293-B264-149262DAF0FAQ34939900-DCB515F1-2BB3-49BB-997C-CD9090F7D6E9Q34939914-D6D93B02-56A1-4FD3-A8B5-2BA8872E2351Q35484325-4F16422E-E7B8-4648-B62E-3FC9FF61E2DFQ35968136-A7365C81-74BC-4ECE-8DA9-57DF8C65B438Q36744366-EC6DEE4F-4554-4EC4-9C25-7C5874CE6BC8Q37094760-58A05ED0-A81A-4353-9AA4-5CBD5F5C15EAQ38515846-7AE18DF9-E2AC-4A90-BF11-FBB9149AF303Q38694075-02CFCD96-9393-4E0C-92EE-B0290A97AF4BQ38721640-00FB2963-2D70-4668-BA7A-AB7F180852A7Q38990121-B469DBC7-AD0F-40CA-BC4B-E47208180A1BQ39209988-6D69984D-628F-4510-8D03-7B41AD922079Q39959986-BEA3915C-DC86-44F1-A741-5460B8D4AFA8Q41891837-9BF1D246-C03C-437C-84AE-78B13E11F890Q42700473-B0D7556A-B714-494C-A205-55BF7455FF92Q43075742-FA1DD4E1-152B-4107-B204-23BB8524E4A8Q43104297-67CCE5B0-B944-457A-A91B-EE2FAF978989Q44339961-03D15BFE-9087-45F4-BE86-619386790DFDQ44341109-C596A52A-87B9-4CDD-B11B-748449B6A14DQ44347852-A2654E28-4291-40C7-BE5A-6A194738F972Q47301262-82DBC2D4-1C54-478D-A5A0-BFB21722544F
P2860
Challenges for opioid receptor nomenclature: IUPHAR Review 9.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenges for opioid receptor nomenclature: IUPHAR Review 9.
@en
type
label
Challenges for opioid receptor nomenclature: IUPHAR Review 9.
@en
prefLabel
Challenges for opioid receptor nomenclature: IUPHAR Review 9.
@en
P2093
P2860
P356
P1476
Challenges for opioid receptor nomenclature: IUPHAR Review 9.
@en
P2093
Brian M Cox
John R Traynor
Lakshmi Devi
Lawrence Toll
Macdonald J Christie
P2860
P304
P356
10.1111/BPH.12612
P407
P577
2014-07-01T00:00:00Z